High-altitude illness (AMS / HACE / HAPE)
Altitude · Environmental
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
A spectrum driven by hypobaric hypoxia on rapid ascent > ~2500 m. AMS (headache + nausea, anorexia, fatigue, dizziness, poor sleep) can progress to HACE (ataxia, confusion, drowsiness → coma from cerebral oedema) and/or HAPE (dyspnoea at rest, cough, pink frothy sputum, crackles — the commonest altitude killer). HACE and HAPE are life-threatening.
Red flags
- Ataxia, confusion, drowsiness or behaviour change (HACE)
- Dyspnoea at rest, cough with frothy/pink sputum, cyanosis (HAPE)
- Failure to improve with oxygen
- Reduced consciousness / coma
Assessment
Differential diagnosis
- Dehydration / exhaustion
- Migraine or tension headache
- Hypothermia
- Hyponatraemia
- Carbon-monoxide exposure (stoves in tents)
- Pneumonia
- Viral illness
- Intracranial pathology
Investigations
- Largely CLINICAL (Lake Louise score for AMS)
- SpO₂ (low for altitude, esp. HAPE)
- Neuro exam — heel-to-toe gait (ataxia = HACE)
- Chest auscultation (crackles = HAPE)
- In hospital: ABG, CXR (patchy infiltrates in HAPE), glucose, U&E to exclude mimics
Management
- Golden rules: do NOT ascend with AMS symptoms; DESCEND for any worsening or for HACE/HAPE; never leave a sick person alone.
- AMS (mild): stop ascending, rest and acclimatise 1–2 days; analgesia + antiemetic; acetazolamide to speed acclimatisation. Improve → may continue.
- AMS (moderate–severe) or not improving: descend 500–1000 m; add dexamethasone; supplemental O₂ / portable hyperbaric bag if available.
- HACE: IMMEDIATE descent (~1000 m) — the priority; dexamethasone; supplemental O₂; portable hyperbaric therapy if descent delayed; airway support if comatose.
- HAPE: IMMEDIATE descent + supplemental O₂ (target SpO₂ > 90%); minimise exertion, keep warm; nifedipine if descent/O₂ limited; portable hyperbaric bag as a bridge.
- Descend to definitive care; treat concurrent HACE + HAPE together.
Drugs & doses
Acetazolamide 125–250 mg PO BD (treatment/acclimatisation; 125 mg BD from 1 day before ascent for prevention)
Dexamethasone — AMS: 4 mg PO/IM/IV q6h. HACE: 8 mg once, then 4 mg q6h
Nifedipine 30 mg modified-release PO BD for HAPE (alternatives: tadalafil/sildenafil)
Supplemental oxygen; analgesia (paracetamol/ibuprofen) + antiemetic (ondansetron) for AMS symptoms
Disposition
Mild AMS → rest/acclimatise in the field. HACE/HAPE or severe AMS → descend + evacuate to hospital; admit for oxygen and monitoring.
Complications & pitfalls
- Cerebral herniation and death (HACE)
- Respiratory failure and death (HAPE)
- Coexisting HACE + HAPE
- Retinal haemorrhage; thromboembolism
Exam pearls
- Descent is the definitive treatment for HACE and HAPE — drugs and oxygen only buy time.
- Dexamethasone treats the brain (HACE); nifedipine treats the lungs (HAPE); acetazolamide aids acclimatisation.
- New ataxia at altitude is HACE until proven otherwise — descend now.
- A person on dexamethasone may feel well enough to climb — they must still descend, not ascend.
Never ascend with symptoms; descend for any deterioration. HACE and HAPE are emergencies — descend + oxygen ± dexamethasone (brain) / nifedipine (lungs).
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.